Tag: drug market protection

Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection

Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, incentivizing development where profits are low. Learn how it works, how it compares to Europe, and why it's both vital and controversial.

learn more